go back

Rhode Island rates for HCPCS C9076

Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $436,516 · 10th–90th $436,516–$457,0880%50%90th$436,516Professionalmedian $446,684 · 10th–90th $446,684–$446,6840%50%100%$446,684$500.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample — interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
BCBS
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$436,515.83 / $436,515.83 / $457,088.19
BCBS
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$446,683.59 / $446,683.59 / $446,683.59